Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569594 · ClinicalTrials.gov registry record
CorMatrix ECM for Carotid Repair Following Endarterectomy Registry
A clinical trial, sponsored by Elutia.
- Completed
- Registry status
- 230
- Enrollment target
NCT01569594: Completed study, sponsored by Elutia.
NCT01569594 is a clinical trial that has completed, run by Elutia. The registered enrollment target is 230 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01569594 has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
Study Summary
Assess device performance data from subjects undergoing patch angioplasty of the carotid artery following carotid endarterectomy using the CorMatrix ECM for Carotid Repair.
Interventions
- DEVICE CorMatrix ECM for Carotid Repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-12-31 |
What the finished NCT01569594 record still lists
NCT01569594 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CorMatrix ECM for Carotid Repair is the first listed.
NCT01569594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01569594 about?
NCT01569594 is a clinical study titled "CorMatrix ECM for Carotid Repair Following Endarterectomy Registry". Assess device performance data from subjects undergoing patch angioplasty of the carotid artery following carotid endarterectomy using the CorMatrix ECM for Carotid Repair.
What is the current status of trial NCT01569594?
This trial is currently completed. The enrollment target is 230 participants. The study started on 2012-04. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT01569594?
The interventions under investigation include: CorMatrix ECM for Carotid Repair (DEVICE).
Who is sponsoring clinical trial NCT01569594?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia